NEPWA
GILD icon

New England Private Wealth Advisors’s Gilead Sciences GILD Stock Holding History

New England Private Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,780
Closed -$208K – 113
2015
Q2 		$208K Buy
+1,780
New +$195K 0.08% 102

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

New England Private Wealth Advisors's GILD Position: Q3 2015 in Review

New England Private Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 1,780 shares — an estimated $208K sold.

New England Private Wealth Advisors first reported a position in GILD in Q2 2015 and held it in 1 quarter. The position peaked at $208K in Q2 2015. 1,575 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • New England Private Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • New England Private Wealth Advisors sold 1,780 Gilead Sciences shares in Q3 2015, an estimated $208K.
  • New England Private Wealth Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 1 quarter.
  • New England Private Wealth Advisors's Gilead Sciences position peaked at $208K in Q2 2015.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on New England Private Wealth Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.